Surgical Resection Improves Overall Survival in cT4b Major Salivary Gland Cancer.
Aman M PatelAfash HaleemHassaam S ChoudhryJason A BrantRobert M BrodyRyan M CareyPublished in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2024)
A minority of patients with cT4b MSGC undergo definitive treatment. Surgical resection + adjuvant therapy was safe and associated with higher OS than definitive RT or CRT, despite high rate of PSM. In the absence of clinical trial data, appropriately selected patients with cT4b MSGC may benefit from surgical resection.
Keyphrases
- image quality
- dual energy
- computed tomography
- contrast enhanced
- clinical trial
- positron emission tomography
- magnetic resonance imaging
- locally advanced
- magnetic resonance
- randomized controlled trial
- heart failure
- electronic health record
- machine learning
- cardiac resynchronization therapy
- free survival
- replacement therapy